Back to Results
First PageMeta Content
Amides / Dipeptidyl peptidase-4 inhibitors / Bristol-Myers Squibb / Nitriles / Metformin / Dapagliflozin / Anti-diabetic medication / Saxagliptin / Sulfonylurea / Chemistry / Organic chemistry / Anti-diabetic drugs


Document Date: 2015-04-22 23:39:46

Open Document

File Size: 123,79 KB

Share Result on Facebook

City

Trial / Trials / /

Company

Parallelgroup / AstraZeneca Pty Ltd / PBAC Meeting FDC / /

Country

Australia / /

Currency

USD / /

Event

FDA Phase / Product Issues / Music Album Release / Reorganization / /

IndustryTerm

treatment algorithm / /

MedicalCondition

genital mycotic infections / AP Diabetes mellitus / diabetes / print Diabetes / Internal study report Diabetes / diabetes mellitus / genital infections 2009a / Obesity / urinary tract infections / II diabetes / /

MedicalTreatment

alternative therapy / alternative therapies / oral therapy / /

MusicAlbum

Source / /

Organization

Federal Government / XR AstraZeneca Authority / /

Person

Bastien Bastien / /

Position

nurse / /

Product

500mg / XR tablets / 5mg / IR tablets / glucagon / Glucophage / XR tablet / 10mg / IR tablet / METFORMIN HYDROCHLORIDE / EXTENDED RELEASE Tablet / CT-014 / CT-691 / CT-065 / Dapagliflozin / Glycaemic Control / /

PublishedMedium

The Lancet / /

Technology

treatment algorithm / submission Trial ID Protocol / Trial ID Protocol / PBSsubsidised treatment algorithm / /

SocialTag